Precipio, Inc. Common Stock

Precipio Inc. (NASDAQ: PRPO) is urging shareholders to vote immediately to reach the 50% quorum requirement for its Annual Shareholders Meeting scheduled for June 15, 2026. As of the press release date, only 42% of shares had been voted. The company is seeking to avoid costly adjournment and rescheduling expenses if sufficient votes are not recei...

Precipio, Inc. (NASDAQ: PRPO), a specialty cancer diagnostics company, announced it will present at the Planet MicroCap Las Vegas 2026 conference on June 17, 2026. CEO Ilan Danieli and COO Zaki Sabet will host the presentation. The company emphasized it is profitable and focused on raising awareness and building its shareholder base rather than r...

Precipio, Inc. (NASDAQ: PRPO) reported Q1-2026 revenue of $6.71M, essentially flat compared to Q4-2025, driven by timing dynamics including delayed product shipments and CMS cuts. Adjusted EBITDA declined to $(0.16)M from $0.96M in Q4-2025, impacted by lower gross profits, new hiring costs, and bonus payments. Management attributes the flat perfo...

Precipio, Inc. (NASDAQ: PRPO) announced that 2025 employee stock options for management vested after the company's stock price increased 400% to a 10-day VWAP of $30.30 from the grant price of $6.06. The company replaced traditional time-based vesting with market-based vesting to align management incentives with shareholder interests. A similar s...

Precipio, Inc. (NASDAQ: PRPO), a specialty cancer diagnostics company, announced it will host its Q1-2026 shareholder update call on May 18th, 2026, at 5:00 PM ET. The call will feature management remarks on core businesses and will mark the first time the company incorporates a dedicated moderated live Q&A session into its quarterly update call,...